Plain-English translation of NCT06480786 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing spinal cord stimulation—a treatment where a small device is surgically placed near your spinal cord to send gentle electrical signals that may reduce pain—for people who have both painful nerve damage from diabetes and leg pain from poor blood circulation. The study will compare the active treatment to a sham (fake) version to see if the real device truly helps reduce pain and improve quality of life.
Many people with diabetes and poor blood circulation suffer from severe leg pain that doesn't respond well to standard pain medications, and this pain makes it hard to exercise and stay active. While this treatment has been used for other types of chronic pain, it has never been properly tested in a rigorous scientific study for this specific combination of conditions.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have the spinal cord stimulator permanently implanted, then return for a follow-up visit 12 weeks later for fine-tuning. After that, you will be randomly assigned to receive either the active treatment or a sham (inactive) version for two weeks each, then switch to the other group. Throughout the study, researchers will measure your pain levels and quality of life to see if the treatment helps.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States